Geneviève Gueguen‐Dorbes

Author

Also Known As

Geneviève Gueguen-Dorbes, Geneviève Gueguen‐Dorbes

Publications

123

Citations

H-Index

Concepts

All Affiliations

Geneviève Gueguen‐Dorbes is an author at Sanofi (France) specializing in radiation oncology, tumor biology, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	108
2	Cell Biology	1	1	25
3	Immunology	1	1	83
4	Pharmacology	1	1	83
5	Cancer Cell Biology	1	1	25

Geneviève Gueguen‐Dorbes

Publications

119

Citations

H-Index

Page 1

	Year	Citations
SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities Antoine Alam, Isabelle Blanc, Geneviève Gueguen‐Dorbes, Molecular Cancer Therapeutics Tam InvasionOncologyMedicineTumor GrowthImmunology	2012	83
Tumor Vasculature Is Regulated by FGF/FGFR Signaling‐Mediated Angiogenesis and Bone Marrow‐Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs Pierre Fons, Geneviève Gueguen‐Dorbes, Jean-Pascal Hérault, Journal of Cellular Physiology Tumor BiologyTumor AngiogenesisAngiogenesisTumor ImmunityCancer Cell Biology	2014	25
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy Michaël R. Paillasse, Michaël Esquerré, Florie A. Bertrand, Cancer Research Communications	2022	11

Page 1